Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Expands By 148.8%

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 220,700 shares, an increase of 148.8% from the December 15th total of 88,700 shares. Approximately 3.1% of the shares of the company are short sold. Based on an average trading volume of 470,100 shares, the short-interest ratio is presently 0.5 days.

Sol-Gel Technologies Price Performance

Shares of NASDAQ SLGL traded down $0.09 during mid-day trading on Thursday, hitting $1.21. The company had a trading volume of 132,815 shares, compared to its average volume of 564,422. Sol-Gel Technologies has a 12 month low of $0.33 and a 12 month high of $1.65. The stock has a market cap of $33.80 million, a price-to-earnings ratio of -3.57 and a beta of 1.34. The firm’s 50 day simple moving average is $0.75 and its two-hundred day simple moving average is $0.68.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.